← Back to Search

Peanut Protein Powder for Surgery

N/A
Waitlist Available
Research Sponsored by Auburn University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 0-6 weeks, 6-12 weeks
Awards & highlights

Study Summary

This trial will study the effects of peanut protein on muscle size and quality in patients undergoing knee surgery.

Eligible Conditions
  • Surgery

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~0-6 weeks, 6-12 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 0-6 weeks, 6-12 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in mid-thigh skeletal muscle area
Change in mid-thigh skeletal muscle area and quality
Secondary outcome measures
Change in inflammatory biomarkers
Change in leg extensor isokinetic dynamometry
Oxford Knee Score
+2 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Immediate Intervention GroupExperimental Treatment2 Interventions
Participants will complete baseline measures and begin daily supplementation of peanut protein powder (72g/day) 7 days prior to total knee arthroplasty until 6 weeks after surgery.
Group II: Wait-llist Control GroupActive Control1 Intervention
Participants will complete baseline measures 7 days prior to total knee arthroplasty and will receive a 7 week supply after completion of 12 week post-surgery visit.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Peanut Protein Powder
2019
N/A
~50

Find a Location

Who is running the clinical trial?

Auburn UniversityLead Sponsor
72 Previous Clinical Trials
14,404 Total Patients Enrolled
Edward Via College of Osteopathic Medicine-AuburnUNKNOWN
1 Previous Clinical Trials
56 Total Patients Enrolled
Jack Hughston Memorial HospitalUNKNOWN

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is enrollment into this experiment available to the public?

"Clinicaltrials.gov asserts that this experiment is still recruiting participants, having been first advertised on August 1st 2021 and most recently revised April 12th 2022."

Answered by AI

Is there an opportunity for me to participate in this investigation?

"This trial is willing to consider 30 individuals who suffer from muscular atrophy and are between 60-75 years of age. Notably, the following conditions must be met: they have a total knee arthroplasty scheduled in two weeks or less under the supervision of doctors at Jack Hughston Clinic."

Answered by AI

What are the main goals of this trial?

"The primary purpose of the study, evaluated over a two-month period is to assess changes in mid-thigh skeletal muscle area and quality. Secondary objectives include gauging change in leg extensor isokinetic dynamometry using a BioDex device, physical performance testing utilising the 2 minute walk test, as well as measuring changes in serum C-reactive protein, interleukin 6 levels, tumor necrosis factor alpha concentrations and plasma 8 hydroxy 2’deoxyguanosine measurements."

Answered by AI

What is the current participation rate for this research?

"Affirmative. According to the information available on clinicaltrials.gov, recruitment for this medical trial is still in progress since it was first posted on August 1st 2021 and last updated April 12th 2022. The researchers are looking to include up to 30 patients at one site."

Answered by AI

Does this clinical trial allow for enrolment of participants above the age of 85?

"The eligibility requirements of this medical study necessitate that the participants be between 60 and 75 years old."

Answered by AI
~0 spots leftby Apr 2025